| |
| |
|
| Insider
Information: |
Feener Edward P. |
| Relationship: |
|
| City: |
Salisbury, Wiltshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
72,858 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$887,410 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
72,858 |
|
|
| Total
Value |
$887,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.7
|
| Percentage
Gain/Loss : |
0.0%
|
 165.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-05-20 |
72,858 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
110,534 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
85,234 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
99,828 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-01-16 |
4 |
AS |
$19.20 |
$78,210 |
D/D |
(4,000) |
104,034 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-04-17 |
4 |
AS |
$24.78 |
$99,666 |
D/D |
(4,000) |
100,034 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-07-22 |
4 |
AS |
$18.57 |
$26,004 |
D/D |
(1,400) |
98,634 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-07-23 |
4 |
AS |
$18.65 |
$35,439 |
D/D |
(1,900) |
96,734 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-02-05 |
4 |
AS |
$17.11 |
$1,711 |
D/D |
(100) |
96,634 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-10-16 |
4 |
AS |
$17.00 |
$16,881 |
D/D |
(993) |
95,641 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-10-20 |
4 |
AS |
$17.26 |
$138,090 |
D/D |
(7,900) |
87,741 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-10-21 |
4 |
AS |
$17.65 |
$164,928 |
D/D |
(9,007) |
78,734 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-11-02 |
4 |
AS |
$17.14 |
$102,812 |
D/D |
(6,000) |
72,734 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-02-23 |
4 |
AS |
$31.73 |
$1,041,642 |
D/D |
(31,000) |
54,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-05-03 |
4/A |
AS |
$24.84 |
$149,051 |
D/D |
(6,000) |
48,234 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-05-03 |
4 |
AS |
$24.84 |
$149,051 |
D/D |
(6,000) |
54,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-06-01 |
4 |
AS |
$26.81 |
$691,665 |
D/D |
(25,800) |
22,434 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-06-02 |
4 |
AS |
$26.33 |
$216,696 |
D/D |
(8,200) |
14,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-08-02 |
4 |
AS |
$20.52 |
$123,134 |
D/D |
(6,000) |
8,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-11-01 |
4 |
AS |
$18.07 |
$108,424 |
D/D |
(6,000) |
2,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-08 |
4 |
AS |
$13.01 |
$224,000 |
D/D |
(17,221) |
62,607 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-09 |
4 |
AS |
$13.00 |
$1,300 |
D/D |
(100) |
62,507 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-11 |
4 |
AS |
$13.03 |
$295,514 |
D/D |
(22,679) |
39,828 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-20 |
4 |
AS |
$14.04 |
$397,929 |
D/D |
(28,288) |
62,157 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-09-18 |
4 |
D |
$17.05 |
$42,625 |
D/D |
(2,500) |
108,034 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific OfficerOffice |
• – – |
2016-11-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,034 |
|
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
